MP16-11 JAPANESE PHASE I/II STUDY OF MULTIPEPTIDE-BASED CANCER VACCINE IMA901 AFTER SINGLE-DOSE CYCLOPHOSPHAMIDE IN JAPANESE PATIENTS WITH ADVANCED RENAL CELL CANCER | Zendy

AI Assistant Blog Pricing

MP16-11 JAPANESE PHASE I/II STUDY OF MULTIPEPTIDE-BASED CANCER VACCINE IMA901 AFTER SINGLE-DOSE CYCLOPHOSPHAMIDE IN JAPANESE PATIENTS WITH ADVANCED RENAL CELL CANCER

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.